Synthetic peroxisome proliferator-activated receptor-γ; agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. - Yang,W.S.; Jeng,C.Y.; Wu,T.J. (Diab Care, 2002)